From: Missing clinical trial data: the evidence gap in primary data for potential COVID-19 drugs
Generic name | Search terms |
---|---|
Pirfenidone | Pirfenidone OR Esbriet OR Pirespa OR Etuary |
Hydroxychloroquine sulfate | Hydroxycholoroquine OR Plaquenil OR Hydroquin OR Axemal OR Dolquine or Quensyl or Quinoric |
Azithromycin | Azithromycin OR zithromax OR AzaSite OR Zmax. |
Favipiravir | Favipiravir OR Avigan OR T-705 |
Oseltamivir | Oseltamivir OR oseltamivir phosphate OR tamiflu OR GS-4104 |
Sarilumab | Surilumab OR Kevzara |
Tocilizumab (atlizumab) | Actemra OR Tocilizumab OR Atlizumab |
Remdesivir | Remdesivir OR GS-5734 |
Leflunomide | Leflunomide OR arava OR SU101 |
Interferon-alpha | IFN-A OR interferon alpha |
Lopinavir/ritonavir | Kaletra OR lopinavir OR ritonavir or navir |
Darunavir/ritonavir | Prezista OR Darunavir OR TMC 114. |
Baloxavir marboxil | Baloxavir marboxil OR UNII-505CXM6OHG OR 505CXM6OHG OR 1985606-14-1 OR xofluza |
Umifenovir | Umifenovir OR arbidol OR AR-1I9514 OR UNII-93M09WW4RU OR 131707-25-0 |
Interferon-beta | Interferon-Beta OR ampligen OR Betaseron OR betaferon OR BAY86-5046 OR Interferon beta-1b OR IFN-Beta |
Sofosbuvir | SOFOSBUVIR OR PSI-7977 OR 1190307-88-0 OR SOVALDI OR GS-7977 |
Nitazoxanide | Nitazoxanide Oral Suspension OR Nitazoxanide OR Alinia OR 55981-09-4 OR Nitazoxamide OR Daxon |
APN01 (ACE2 analogue) | APN01 |
Ivermectin | IVERMECTIN OR Ivermectin B1a OR Dihydroavermectin B1a OR 22,23-Dihydroavermectin B1a OR ivermectin H2B1a OR UNII-91Y2202OUW OR CHEBI:63941 |